Here,
let me save us all the trouble:
Question 1: You've become an overnight household name as a consequence of a manufactured controversy. Since then, you've managed to grow a cult-following by engaging the controversy rather than hiding from the attention. Do you enjoy your new celebrity status enough to justify the headaches the media attention has brought you?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 2: Prescription drug prices don't seem to follow the same price trends as most other consumer commodities. Can you cast some insight into the process of pricing a prescription medication? Do you have any thoughts on the fairness of the perception that drug prices are excessively volatile? Is this perception deserved? In either case, what are some of the underlying causes behind prescription drug price volatility?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 3: Do you believe the environment for pricing pharmaceuticals in the United States is optimal, or favorable to innovation and research that best benefits patients?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 4: You've frequently expressed your desire to invest more money in researching new treatments and cures for diseases. What changes or reforms to the United States healthcare industry and relevant regulations would be most effective in maximizing health outcomes for patients?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 5: What is the single most counterproductive aspect of the United States legal and regulatory structure surrounding health care and drug research?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 6: In most colleges, the computer science, computer engineering, and electrical engineering departments are awash with student interest in these majors. Do you feel that the healthcare industry is suffering from a "brain drain" or talent-loss as a result of differences in perceived profitability and ROI for those education dollars? If so: do you expect the common desire to found a Silicon Valley "Unicorn" startup could be redirected to inspire those students to research treatments for diseases if the government changed its approach to healthcare regulations?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 7: In my biology class, I learned that there are many sponges in the mediterranean which appeared to offer opportunities to research new antibiotics. The academic who was researching these sponges lamented about a lack of interest from the pharmaceutical industry in researching new antibiotics because the ones we had now worked "well enough". When I encounter news stories like this: http://www.newsweek.com/2016/0... I'm left with some level of dissonance between two anecdotes which seem impossible to reconcile. Clearly, victims of war are not especially well-equipped to vote with their dollars, but this alleged lack of interest in researching new antibiotics seems endemic of a more systemic issue. Do you believe the search for new antibiotics deserves more research funding than they currently receive? Is there a hype-gap between the threat of antibiotic resistance being portrayed in the media and the risk antibiotic resistance actually poses? Do you believe that antibiotic research funding reflects an appropriate priority level relative to the risk these superbugs pose?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Question 8: Antibiotic resistant tuberculosis is alleged to be a growing problem in some developing countries such as India. Do you believe that this would be less of a problem if generic drugs were unavailable? Would increasing the supply of "affordable antibiotics" likely make this problem better, or worse? Is it hopeless to attack a public health problem by manipulating drug prices, when the core issue is malinvestment in sanitation infrastructure?
"On the advice of counsel I invoke my 5th amendment privilege against self incrimination and respectfully decline to answer your question."
Now we can move on to the next interview.